Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development 2025-10-13 08:10
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 2025-10-11 20:45
Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan 2025-10-10 14:00
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year 2025-10-10 08:30
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept) 2025-10-10 06:56
Amcor Appoints Stephen R. Scherger as Executive Vice President and Chief Financial Officer 2025-10-10 04:30
POMDOCTOR LIMITED Announces Closing of Initial Public Offering 2025-10-10 04:05
Health In Tech Showcases Enhanced eDIYBS Platform at SIIA 2025, Accelerating Broker Growth and Market Reach 2025-10-09 19:30
Samsung Biologics Introduces Optimized Manufacturing Framework, ExellenS™ 2025-10-09 19:00
Advantech AOM-5721 Combines SMARC Design and Qualcomm Dragonwing™ QCS6490 for Next-Gen Edge AI 2025-10-09 17:05
Driving Veterinary Healthcare Forward: Anbio Showcases Diagnostic Portfolio at WSAVA 2025 2025-10-09 11:41
Neopharma Technologies Appoints Singapore Fintech Veteran and Serial Entrepreneur Mr. Joo Seng Wong as Board Advisor to Oversee Institutional Strategy and Global Execution 2025-10-09 09:58
EDAN Expands U.S. Operations with New Manufacturing Hub 2025-10-09 06:53
TCI Biotech Releases 2024 ESG Report, Showcasing Brand Transformation, Global Sustainability Commitments, and Award-Winning Impact 2025-10-08 23:00
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025 2025-10-08 22:20
Alpha Fusion and Kobe City Medical Center General Hospital Establish At-211 Investigational Drug Supply System 2025-10-08 21:00
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering 2025-10-08 20:00
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment 2025-10-08 09:08
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology 2025-10-08 08:15
Celaid Therapeutics Raises JPY 1.055 Billion (USD 7.2 Million) in the First Close of its Series B Financing 2025-10-07 21:00
1 10 11 12 13 14 870